Literature DB >> 16918333

Regulatable gene expression systems for gene therapy.

Nuria Vilaboa1, Richard Voellmy.   

Abstract

It is feasible to restrict transgene expression to a tissue or region in need of therapy by using promoters that respond to focusable physical stimuli. The most extensively investigated promoters of this type are radiation-inducible promoters and heat shock protein gene promoters that can be activated by directed, transient heat. Temporal regulation of transgenes can be achieved by various two- or three-component gene switches that are triggered by an appropriate small molecule inducer. The most commonly considered gene switches that are reviewed herein are based on small molecule-responsive transactivators derived from bacterial tetracycline repressor, insect or mammalian steroid receptors, or mammalian FKBP12/FRAP. A new generation of gene switches combines a heat shock protein gene promoter and a small molecule-responsive gene switch and can provide for both spatial and temporal regulation of transgene activity.

Entities:  

Mesh:

Year:  2006        PMID: 16918333     DOI: 10.2174/156652306777934829

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  215 in total

Review 1.  Steroid and nuclear receptors. Villefranche-sur-Mer, France, May 25-27, 1999.

Authors:  L Di Croce; S Okret; S Kersten; J A Gustafsson; M Parker; W Wahli; M Beato
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

2.  Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.

Authors:  J A Palmer; R H Branston; C E Lilley; M J Robinson; F Groutsi; J Smith; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 3.  Cell-type specific expression in the pituitary: physiology and gene therapy.

Authors:  M G Castro; S Windeatt; J Smith-Arica; P R Lowenstein
Journal:  Biochem Soc Trans       Date:  1999-12       Impact factor: 5.407

4.  Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

5.  Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials.

Authors:  R A Dewey; G Morrissey; C M Cowsill; D Stone; F Bolognani; N J Dodd; T D Southgate; D Klatzmann; H Lassmann; M G Castro; P R Löwenstein
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

6.  Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo.

Authors:  A U Bielinska; A Yen; H L Wu; K M Zahos; R Sun; N D Weiner; J R Baker; B J Roessler
Journal:  Biomaterials       Date:  2000-05       Impact factor: 12.479

7.  A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells.

Authors:  S Freundlieb; C Schirra-Müller; H Bujard
Journal:  J Gene Med       Date:  1999 Jan-Feb       Impact factor: 4.565

8.  Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.

Authors:  N Morral; W O'Neal; K Rice; M Leland; J Kaplan; P A Piedra; H Zhou; R J Parks; R Velji; E Aguilar-Córdova; S Wadsworth; F L Graham; S Kochanek; K D Carey; A L Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

9.  Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.

Authors:  M Christ; B Louis; F Stoeckel; A Dieterle; L Grave; D Dreyer; J Kintz; D Ali Hadji; M Lusky; M Mehtali
Journal:  Hum Gene Ther       Date:  2000-02-10       Impact factor: 5.695

10.  Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody.

Authors:  S Li; Y Tan; E Viroonchatapan; B R Pitt; L Huang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-03       Impact factor: 5.464

View more
  16 in total

Review 1.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

2.  Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging.

Authors:  M Sato; M L Figueiredo; J B Burton; M Johnson; M Chen; R Powell; S S Gambhir; M Carey; L Wu
Journal:  Gene Ther       Date:  2008-02-28       Impact factor: 5.250

3.  An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression.

Authors:  Joseph E Doherty; Lauren E Woodard; Adham S Bear; Aaron E Foster; Matthew H Wilson
Journal:  FASEB J       Date:  2013-06-10       Impact factor: 5.191

4.  Spatiotemporally-controlled transgene expression in hydroxyapatite-fibrin composite scaffolds using high intensity focused ultrasound.

Authors:  Alexander Moncion; Jonah S Harmon; Yan Li; Sam Natla; Easton C Farrell; Oliver D Kripfgans; Jan P Stegemann; Francisco M Martín-Saavedra; Nuria Vilaboa; Renny T Franceschi; Mario L Fabiilli
Journal:  Biomaterials       Date:  2018-12-13       Impact factor: 12.479

5.  Temporal and spatial patterning of transgene expression by near-infrared irradiation.

Authors:  Francisco M Martin-Saavedra; Virginia Cebrian; Leyre Gomez; Daniel Lopez; Manuel Arruebo; Christopher G Wilson; Renny T Franceschi; Richard Voellmy; Jesus Santamaria; Nuria Vilaboa
Journal:  Biomaterials       Date:  2014-06-21       Impact factor: 12.479

6.  Spatial control of gene expression within a scaffold by localized inducer release.

Authors:  Priya R Baraniak; Devin M Nelson; Cory E Leeson; Anand K Katakam; Jennifer L Friz; Dean E Cress; Yi Hong; Jianjun Guan; William R Wagner
Journal:  Biomaterials       Date:  2011-01-26       Impact factor: 12.479

7.  Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.

Authors:  Weibo Cai; Zachary J Kerner; Hao Hong; Jiangtao Sun
Journal:  Biochem Insights       Date:  2008-07-22

8.  A novel estrogen receptor intramolecular folding-based titratable transgene expression system.

Authors:  Ramasamy Paulmurugan; Parasuraman Padmanabhan; Byeong-Cheol Ahn; Sunetra Ray; Juergen K Willmann; Tarik F Massoud; Sandip Biswal; Sanjiv S Gambhir
Journal:  Mol Ther       Date:  2009-08-04       Impact factor: 11.454

9.  Image-guided, noninvasive, spatiotemporal control of gene expression.

Authors:  Roel Deckers; Bruno Quesson; Josette Arsaut; Sandrine Eimer; Franck Couillaud; Chrit T W Moonen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

Review 10.  Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.

Authors:  Sander W Tas; Margriet J B M Vervoordeldonk; Paul P Tak
Journal:  Curr Gene Ther       Date:  2009-06       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.